Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 18, 2025
Product Development

2025 catalysts: New modality showdowns 

Genetic therapies compete in the same indications, as degraders come of age
BioCentury | Jul 26, 2012
Distillery Therapeutics

Indication: Neurology

BioCentury | Jul 5, 2010
Emerging Company Profile

ProNoxis: Promoting ROS

ProNoxis hopes reactive oxygen species provide a benefit in rheumatoid arthritis
BioCentury | Dec 9, 2002
Company News

Arexis other research news

Items per page:
1 - 4 of 4